One-Year Toxicity of Ultrahypofractionated Breast Radiotherapy (+/- Sequential Boost) and a Survey of Patient Experience

PURPOSE/OBJECTIVE(S): In March 2020, a 1-week hypofractionated adjuvant breast radiotherapy schedule, 26 Gy in 5 fractions, was implemented to reduce the risk of COVID 19 virus for patients and staff without compromising on cancer outcomes. This prospective observational study aims to report late to...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholson, J., Nugent, K., Farmer, G., Monaghan, O., O'Driscoll, H., Cleary, S., McArdle, O., Duane, F.K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595472/
http://dx.doi.org/10.1016/j.ijrobp.2022.07.694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9595472/
http://dx.doi.org/10.1016/j.ijrobp.2022.07.694

Ejemplares similares